FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319441885> ?p ?o ?g. }

• W4319441885 endingPage "1298" @default.
• W4319441885 startingPage "1298" @default.
• W4319441885 abstract "Introduction: Ventilator-associated pneumonia (VAP) incidence is high among critically ill COVID-19 patients. Its attributable mortality remains underestimated, especially for unresolved episodes. Indeed, the impact of therapeutic failures and the determinants that potentially affect mortality are poorly evaluated. We assessed the prognosis of VAP in severe COVID-19 cases and the impact of relapse, superinfection, and treatment failure on 60-day mortality. Methods: We evaluated the incidence of VAP in a multicenter prospective cohort that included adult patients with severe COVID-19, who required mechanical ventilation for ≥48 h between March 2020 and June 2021. We investigated the risk factors for 30-day and 60-day mortality, and the factors associated with relapse, superinfection, and treatment failure. Results: Among 1424 patients admitted to eleven centers, 540 were invasively ventilated for 48 h or more, and 231 had VAP episodes, which were caused by Enterobacterales (49.8%), P. aeruginosa (24.8%), and S. aureus (22%). The VAP incidence rate was 45.6/1000 ventilator days, and the cumulative incidence at Day 30 was 60%. VAP increased the duration of mechanical ventilation without modifying the crude 60-day death rate (47.6% vs. 44.7% without VAP) and resulted in a 36% increase in death hazard. Late-onset pneumonia represented 179 episodes (78.2%) and was responsible for a 56% increase in death hazard. The cumulative incidence rates of relapse and superinfection were 45% and 39.5%, respectively, but did not impact death hazard. Superinfection was more frequently related to ECMO and first episode of VAP caused by non-fermenting bacteria. The risk factors for treatment failure were an absence of highly susceptible microorganisms and vasopressor need at VAP onset. Conclusions: The incidence of VAP, mainly late-onset episodes, is high in COVID-19 patients and associated with an increased risk of death, similar to that observed in other mechanically ventilated patients. The high rate of VAP due to difficult-to-treat microorganisms, pharmacokinetic alterations induced by renal replacement therapy, shock, and ECMO likely explains the high cumulative risk of relapse, superinfection, and treatment failure." @default.
• W4319441885 created "2023-02-09" @default.
• W4319441885 creator A5009850085 @default.
• W4319441885 creator A5012201847 @default.
• W4319441885 creator A5013290885 @default.
• W4319441885 creator A5015124748 @default.
• W4319441885 creator A5022627748 @default.
• W4319441885 creator A5023138053 @default.
• W4319441885 creator A5039514260 @default.
• W4319441885 creator A5043182712 @default.
• W4319441885 creator A5047104463 @default.
• W4319441885 creator A5074263021 @default.
• W4319441885 creator A5075715397 @default.
• W4319441885 creator A5082420078 @default.
• W4319441885 creator A5083109457 @default.
• W4319441885 creator A5088300926 @default.
• W4319441885 date "2023-02-06" @default.
• W4319441885 modified "2023-10-16" @default.
• W4319441885 title "Ventilator-Associated Pneumonia in COVID-19 Patients Admitted in Intensive Care Units: Relapse, Therapeutic Failure and Attributable Mortality—A Multicentric Observational Study from the OutcomeRea Network" @default.
• W4319441885 cites W2001297452 @default.
• W4319441885 cites W2011813012 @default.
• W4319441885 cites W2058840909 @default.
• W4319441885 cites W2107777867 @default.
• W4319441885 cites W2114324593 @default.
• W4319441885 cites W2132185712 @default.
• W4319441885 cites W2473016454 @default.
• W4319441885 cites W2709921813 @default.
• W4319441885 cites W2752537900 @default.
• W4319441885 cites W2770047794 @default.
• W4319441885 cites W2773548512 @default.
• W4319441885 cites W2801686627 @default.
• W4319441885 cites W2805167945 @default.
• W4319441885 cites W2897009687 @default.
• W4319441885 cites W2906867017 @default.
• W4319441885 cites W2912119144 @default.
• W4319441885 cites W2947606651 @default.
• W4319441885 cites W2975920332 @default.
• W4319441885 cites W3011452295 @default.
• W4319441885 cites W3016697657 @default.
• W4319441885 cites W3046635636 @default.
• W4319441885 cites W3103789918 @default.
• W4319441885 cites W3107560405 @default.
• W4319441885 cites W3109084335 @default.
• W4319441885 cites W3115279269 @default.
• W4319441885 cites W3118419263 @default.
• W4319441885 cites W3127525338 @default.
• W4319441885 cites W3128936664 @default.
• W4319441885 cites W3129009830 @default.
• W4319441885 cites W3132527202 @default.
• W4319441885 cites W3139014590 @default.
• W4319441885 cites W3155954513 @default.
• W4319441885 cites W3159858666 @default.
• W4319441885 cites W3164940806 @default.
• W4319441885 cites W3165680070 @default.
• W4319441885 cites W3176816419 @default.
• W4319441885 cites W3186826841 @default.
• W4319441885 cites W3198281358 @default.
• W4319441885 cites W4205823937 @default.
• W4319441885 cites W4206449744 @default.
• W4319441885 cites W4225624919 @default.
• W4319441885 cites W4225807355 @default.
• W4319441885 cites W4229010378 @default.
• W4319441885 cites W4237644445 @default.
• W4319441885 cites W4283461877 @default.
• W4319441885 cites W4289522791 @default.
• W4319441885 doi "https://doi.org/10.3390/jcm12041298" @default.
• W4319441885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36835834" @default.
• W4319441885 hasPublicationYear "2023" @default.
• W4319441885 type Work @default.
• W4319441885 citedByCount "4" @default.
• W4319441885 countsByYear W43194418852023 @default.
• W4319441885 crossrefType "journal-article" @default.
• W4319441885 hasAuthorship W4319441885A5009850085 @default.
• W4319441885 hasAuthorship W4319441885A5012201847 @default.
• W4319441885 hasAuthorship W4319441885A5013290885 @default.
• W4319441885 hasAuthorship W4319441885A5015124748 @default.
• W4319441885 hasAuthorship W4319441885A5022627748 @default.
• W4319441885 hasAuthorship W4319441885A5023138053 @default.
• W4319441885 hasAuthorship W4319441885A5039514260 @default.
• W4319441885 hasAuthorship W4319441885A5043182712 @default.
• W4319441885 hasAuthorship W4319441885A5047104463 @default.
• W4319441885 hasAuthorship W4319441885A5074263021 @default.
• W4319441885 hasAuthorship W4319441885A5075715397 @default.
• W4319441885 hasAuthorship W4319441885A5082420078 @default.
• W4319441885 hasAuthorship W4319441885A5083109457 @default.
• W4319441885 hasAuthorship W4319441885A5088300926 @default.
• W4319441885 hasBestOaLocation W43194418851 @default.
• W4319441885 hasConcept C120665830 @default.
• W4319441885 hasConcept C121332964 @default.
• W4319441885 hasConcept C126322002 @default.
• W4319441885 hasConcept C179755657 @default.
• W4319441885 hasConcept C188816634 @default.
• W4319441885 hasConcept C201903717 @default.
• W4319441885 hasConcept C203014093 @default.
• W4319441885 hasConcept C207103383 @default.
• W4319441885 hasConcept C2522874641 @default.
• W4319441885 hasConcept C2777080012 @default.
• W4319441885 hasConcept C2777184939 @default.

• next